The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction

Journal of the American College of Cardiology

Volumn 35, Issue 3, 2000, Pages 681-689

  Dries, Daniel L ^a   Exner, Derek V ^b   Domanski, Michael J ^b   Greenberg, Barry ^c   Stevenson, Lynne W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Clinical Trials Research Group   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAUSE OF DEATH; CREATININE; DISEASE PROGRESSION; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034163914     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00608-7     Document Type: Article

References (12)

1. Abraham WT, Schrier RW. Diseases of the kidney. In: Schrier RW, Gottschalk CW, editors. Cardiac Failure, Liver Disease and Nephrotic Syndrome. Little, Brown and Company, 6th ed. 1997:2353-92.
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
4. The SOLVD Investigators. Studies of left ventricular dysfunction (SOLVD) - rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced left ventricular ejection fractions. Am J Cardiol 1990;66:315-22.
5. Psaty B.M., Heckbert H.R., Koepsell T.D., et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 274:1995;62-65.
6. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 319:1988;385-392.
7. Redfield M.M., Aarhus L.L., Wright R.S., Burnett J.C. Cardiorenal andneurohormonal function in a canine model of early left ventricular dysfunction. Circulation. 87:1993;2016-2022.
8. Madsen B.K., Hansen J.F., Stokholm K.H., Brons J., Husum D., Mortensen L.S. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J. 15:1994;303-310.
9. Spinar J., Vitovec J., Spac J., Blaha M., Spinarova L., Toman J. Noninvasive prognostic factors in chronic heart failure. One-year survival of 300 patients with a diagnosis of chronic heart failure due to ischemic heart disease or dilated cardiomyopathy. Int J Cardiol. 56:1996;283-288.
10. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 325:1991;1468-1475.
11. Obasohan A.O., Ajuyah C.O. Heart failure in Nigerian hypertensive patients the role of renal dysfunction . Int J Cardiol. 52:1995;251-255.
12. Ziesche S., Rector T.S., Cohn J.N. Interobserver discordance in the classification of mechanisms of death in studies of heart failure. J Card Fail. 1:1995;127-132.